BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2577281)

  • 1. Myocardial, coronary, and peripheral effects of xamoterol (ICI 118,587) in open-chest pigs.
    Galiè N; Metalli M; Zannoli R; Binetti G; Branzi A; Magnani B
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):91-7. PubMed ID: 2577281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of xamoterol on myocardial energetics in man.
    Sakai O; Fujita M; Sasayama S; Asanoi H; Nakajima H; Yokawa S
    Jpn Circ J; 1988 Feb; 52(2):149-54. PubMed ID: 2896256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
    Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK
    Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease.
    Pouleur H; van Eyll C; Etienne J; van Mechelen H; Vuylsteke A; Rousseau MF
    Basic Res Cardiol; 1989; 84 Suppl 1():157-62. PubMed ID: 2573338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.
    Nuttall A; Snow HM
    Br J Pharmacol; 1982 Oct; 77(2):381-8. PubMed ID: 6128041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of the inotropic effects of the beta 1-adrenoceptor partial agonists SL 75.177.10 and ICI 118,587 with digoxin on the intact canine heart.
    Pouleur H; Van Mechelen H; Balasim H; Rousseau MF; Charlier AA
    J Cardiovasc Pharmacol; 1984; 6(4):720-6. PubMed ID: 6206332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single and combined myocardial pharmacodynamics of xamoterol, isoprenaline and g-strophanthin in the isolated rabbit heart.
    Vigholt Sørensen E; Nielsen-Kudsk F
    Eur J Pharmacol; 1986 Jun; 125(3):363-71. PubMed ID: 2874040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular actions of xamoterol (ICI 118,587) in anaesthetized cats, rats, and guinea pigs.
    Mian MA; Malta E; Raper C
    J Cardiovasc Pharmacol; 1986; 8(2):314-23. PubMed ID: 2422470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The partial agonist activity of xamoterol (ICI 118,587) studied by heart rate response in pithed rats.
    Hashimoto T; Kondo K; Shiina A; Toyo-Oka T; Kawasaki K; Kimura K; Hosoda S
    Jpn Circ J; 1988 Jan; 52(1):60-5. PubMed ID: 2896255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial energetics in dilated cardiomyopathy.
    Thierfelder L; Holubarsch CH; Hasenfuss G; Just HJ
    Clin Cardiol; 1990 Sep; 13(9):649-54. PubMed ID: 1976466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
    Tangø M; Carlsen JE; Trap-Jensen J
    Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of xamoterol on peripheral blood vessels in healthy subjects.
    Fitzgerald DE
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):70S-72S. PubMed ID: 2572259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of a partial agonist of beta 1 adrenergic receptors (ICI 118,587) on left ventricular performance and metabolism in coronary disease].
    Rousseau MF; Pouleur H; Etienne J; Mengeot P; Cheron P
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):76-84. PubMed ID: 6142702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
    Duncker DJ; Hartog JM; Hugenholtz PG; Saxena PR; Verdouw PD
    Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1970 May; 38(3):554-71. PubMed ID: 4392541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
    Thierfelder L; Holubarsch C; Hasenfuss G; Heiss HW; Just H
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):593-9. PubMed ID: 1711626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the partial beta 1-adrenergic agonist, xamoterol, on hemodynamics and regional myocardial function during acute coronary occlusion in dogs.
    Miura T; Matsuzaki M; Toma Y; Yonezawa F; Kohno M; Katayama K; Ozaki M; Kumada T; Kusukawa R
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):182-7. PubMed ID: 1689411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.